XML 35 R24.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Note 3 - Revenue (Tables) | 9 Months Ended
--- | ---
Dec. 31, 2024
Notes Tables |
Disaggregation of Revenue [Table Text Block] |
|  | Three Months Ended December 31, 2024 |
|  | Sterilization and Disinfection Control (1) |  |  | Clinical Genomics |  |  | Biopharmaceutical Development |  |  | Calibration Solutions |  |  | Total |
Consumables |  | $ | 20,991 |  |  | $ | 9,866 |  |  | $ | 4,909 |  |  | $ | 1,043 |  |  | $ | 36,809 |
Hardware and software |  |  | 52 |  |  |  | 1,877 |  |  |  | 4,534 |  |  |  | 9,333 |  |  |  | 15,796 |
Services |  |  | 2,464 |  |  |  | 924 |  |  |  | 2,794 |  |  |  | 4,053 |  |  |  | 10,235 |
Total revenues |  | $ | 23,507 |  |  | $ | 12,667 |  |  | $ | 12,237 |  |  | $ | 14,429 |  |  | $ | 62,840 |
|  | Three Months Ended December 31, 2023 |
|  | Sterilization and Disinfection Control (1) |  |  | Clinical Genomics |  |  | Biopharmaceutical Development |  |  | Calibration Solutions |  |  | Total |
Consumables |  | $ | 16,832 |  |  | $ | 9,758 |  |  | $ | 4,080 |  |  | $ | 539 |  |  | $ | 31,209 |
Hardware and software |  |  | 180 |  |  |  | 1,639 |  |  |  | 2,672 |  |  |  | 8,254 |  |  |  | 12,745 |
Services |  |  | 2,326 |  |  |  | 1,149 |  |  |  | 2,678 |  |  |  | 3,366 |  |  |  | 9,519 |
Total revenues |  | $ | 19,338 |  |  | $ | 12,546 |  |  | $ | 9,430 |  |  | $ | 12,159 |  |  | $ | 53,473 |
|  | Nine Months Ended December 31, 2024 |
|  | Sterilization and Disinfection Control (1) |  |  | Clinical Genomics |  |  | Biopharmaceutical Development |  |  | Calibration Solutions |  |  | Total |
Consumables |  | $ | 60,860 |  |  | $ | 26,156 |  |  | $ | 12,657 |  |  | $ | 2,067 |  |  | $ | 101,740 |
Hardware and software |  |  | 365 |  |  |  | 6,511 |  |  |  | 14,539 |  |  |  | 24,067 |  |  |  | 45,482 |
Services |  |  | 7,444 |  |  |  | 2,903 |  |  |  | 8,916 |  |  |  | 12,358 |  |  |  | 31,621 |
Total revenues |  | $ | 68,669 |  |  | $ | 35,570 |  |  | $ | 36,112 |  |  | $ | 38,492 |  |  | $ | 178,843 |
|  | Nine Months Ended December 31, 2023 |
|  | Sterilization and Disinfection Control (1) |  |  | Clinical Genomics |  |  | Biopharmaceutical Development |  |  | Calibration Solutions |  |  | Total |
Consumables |  | $ | 45,288 |  |  | $ | 28,490 |  |  | $ | 12,753 |  |  | $ | 1,834 |  |  | $ | 88,365 |
Hardware and software |  |  | 381 |  |  |  | 9,540 |  |  |  | 7,838 |  |  |  | 22,216 |  |  |  | 39,975 |
Services |  |  | 6,676 |  |  |  | 3,434 |  |  |  | 7,935 |  |  |  | 10,898 |  |  |  | 28,943 |
Total revenues |  | $ | 52,345 |  |  | $ | 41,464 |  |  | $ | 28,526 |  |  | $ | 34,948 |  |  | $ | 157,283 |
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] |
|  | Three Months Ended December 31, |  |  | Nine Months Ended December 31, |
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
United States |  | $ | 30,476 |  |  | $ | 25,595 |  |  | $ | 85,415 |  |  | $ | 79,205 |
China |  |  | 6,322 |  |  |  | 4,942 |  |  |  | 20,271 |  |  |  | 18,584 |
Other |  |  | 26,042 |  |  |  | 22,936 |  |  |  | 73,157 |  |  |  | 59,494 |
Total revenues |  | $ | 62,840 |  |  | $ | 53,473 |  |  | $ | 178,843 |  |  | $ | 157,283 |
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] |
Contract liabilities as of March 31, 2024 |  | $ | 15,686 |
Prior year liabilities recognized in revenues during the nine months ended December 31, 2024 |  |  | (9,069 | )
Contract liabilities added during the nine months ended December 31, 2024, net of revenues recognized |  |  | 8,083 |
Contract liabilities as of December 31, 2024 |  | $ | 14,700 |

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration